Session 11: AI & The Future of Benign Haematology
Tracks
Plenary Hall
| Sunday, October 18, 2026 |
| 11:45 AM - 12:15 PM |
Speaker
Prof. Drew Provan
Emeritus Reader in Autoimmune Haematology
Barts and The London School of Medicine and Dentistry
AI in My Clinic: What’s Real, What’s Hype?
11:45 AM - 12:00 PMBiography
Dr. Drew Provan is Emeritus Reader in Autoimmune Haematology at Barts and The London School of Medicine and Dentistry. He originally studied molecular genetics before training in medicine, and later undertook research at the Dana–Farber Cancer Institute in Boston as an MRC Travelling Fellow. Dr Provan is a leading authority in immunohaematology, with a major focus on immune thrombocytopenia, neutropenia and haemolytic anaemia. He helped establish the UK ITP Registry and is a senior author of the International Consensus Guidelines for the diagnosis and management of ITP in adults and children. He has published extensively in the field and is author of several well-known medical texts, including Molecular Haematology, the Oxford Handbook of Clinical Haematology, and the ABC of Clinical Haematology.
Dr. Namrata Singh
Founder & CEO
Turacoz Group
Leveraging AI for Video and Graphical Abstract in Hematology Publications
12:00 PM - 12:15 PMBiography
Dr Namrata is a distinguished pediatrician, medical writer, and visionary leader dedicated to transforming healthcare for children. As Founder & CEO of Turacoz Group, she bridges medical knowledge and effective communication, simplifying complex concepts for diverse audiences. A passionate mentor, she fosters growth and collaboration, while also promoting healthy lifestyles for young individuals. Known for her determination, excellence, and compassion, Dr Namrata inspires through her leadership and commitment to positive change.
Session Chair
Ahmad Tarawah
President, Madinah Hereditary Blood Disorders Society
President, Middle East and North Africa Hematology League